Subcutaneous epcoritamab in combination with R (2) (rituximab and lenalidomide) in patients with relapsed or refractory follicular lymphoma: Preliminary results from a phase 1/2 trial Meeting Abstract
| Authors: | Linton, K. M.; Wahlin, B.; Leepa, S.; Morschhauser, F.; Elliot, B.; Liu, T.; Stirner, M. C.; Abbas, A.; Falchi, L. |
| Abstract Title: | Subcutaneous epcoritamab in combination with R (2) (rituximab and lenalidomide) in patients with relapsed or refractory follicular lymphoma: Preliminary results from a phase 1/2 trial |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413906102 |
| DOI: | 10.1182/blood-2021-146629 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3535 -- Hybrid meeting, also took place online -- Source: Wos |
